TY - STD TI - Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–62. ID - ref1 ER - TY - JOUR AU - Shen, L. AU - Shan, Y. S. AU - Hu, H. M. AU - Price, T. J. AU - Sirohi, B. AU - Yeh, K. H. PY - 2013 DA - 2013// TI - Management of gastric cancer in Asia: resource-stratified guidelines JO - Lancet VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70436-4 DO - 10.1016/S1470-2045(13)70436-4 ID - Shen2013 ER - TY - JOUR AU - Okabe, H. AU - Hata, H. AU - Ueda, S. AU - Zaima, M. AU - Tokuka, A. AU - Yoshimura, T. PY - 2016 DA - 2016// TI - A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03 JO - J Surg Oncol VL - 11 UR - https://doi.org/10.1002/jso.24096 DO - 10.1002/jso.24096 ID - Okabe2016 ER - TY - JOUR AU - Feng, W. M. AU - Tang, C. W. AU - Guo, H. H. AU - Bao, Y. AU - Fei, M. Y. PY - 2015 DA - 2015// TI - Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy JO - Biomed Pharmacother VL - 72 UR - https://doi.org/10.1016/j.biopha.2015.03.003 DO - 10.1016/j.biopha.2015.03.003 ID - Feng2015 ER - TY - JOUR AU - Rosenberg, S. A. AU - Lotze, M. T. AU - Muul, L. M. AU - Chang, A. E. AU - Avis, F. P. AU - Leitman, S. PY - 1987 DA - 1987// TI - A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone JO - N Engl J Med VL - 316 UR - https://doi.org/10.1056/NEJM198704093161501 DO - 10.1056/NEJM198704093161501 ID - Rosenberg1987 ER - TY - JOUR AU - Katano, M. AU - Morisaki, T. AU - Koga, K. AU - Nakamura, M. AU - Onishi, H. AU - Matsumoto, K. PY - 2005 DA - 2005// TI - Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas JO - Anticancer Res VL - 25 ID - Katano2005 ER - TY - JOUR AU - Nakamura, M. AU - Wada, J. AU - Suzuki, H. AU - Tanaka, M. AU - Katano, M. AU - Morisaki, T. PY - 2009 DA - 2009// TI - Long-term outcome of immunotherapy for patients with refractory pancreatic cancer JO - Anticancer Res VL - 29 ID - Nakamura2009 ER - TY - JOUR AU - Wada, J. AU - Yamasaki, A. AU - Nagai, S. AU - Yanai, K. AU - Fuchino, K. AU - Kameda, C. PY - 2008 DA - 2008// TI - Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients JO - Anticancer Res VL - 28 ID - Wada2008 ER - TY - JOUR AU - Morisaki, T. AU - Hirano, T. AU - Koya, N. AU - Kiyota, A. AU - Tanaka, H. AU - Umebayashi, M. PY - 2014 DA - 2014// TI - NKG2D-directed cytokine-activated killer lymphocyte therapy combined with gemcitabine for patients with chemoresistant metastatic solid tumors JO - Anticancer Res VL - 34 ID - Morisaki2014 ER - TY - JOUR AU - Onishi, H. AU - Koya, N. AU - Kiyota, A. AU - Tanaka, H. AU - Umebayashi, M. AU - Katano, M. AU - Morisaki, T. PY - 2012 DA - 2012// TI - A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail JO - Anticancer Res VL - 32 ID - Onishi2012 ER - TY - JOUR AU - Yoshida, K. AU - Yamaguchi, K. AU - Okumura, N. AU - Tanahashi, T. AU - Kodera, Y. PY - 2016 DA - 2016// TI - Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification JO - Gastric Cancer VL - 19 UR - https://doi.org/10.1007/s10120-015-0575-z DO - 10.1007/s10120-015-0575-z ID - Yoshida2016 ER - TY - JOUR AU - Kimura, H. AU - Yamaguchi, Y. PY - 1995 DA - 1995// TI - Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer JO - Lung Cancer VL - 13 UR - https://doi.org/10.1016/0169-5002(95)00478-J DO - 10.1016/0169-5002(95)00478-J ID - Kimura1995 ER - TY - JOUR AU - Kimura, H. AU - Matsui, Y. AU - Ishikawa, A. AU - Nakajima, T. AU - Yoshino, M. AU - Sakairi, Y. PY - 2015 DA - 2015// TI - Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer JO - Cancer Immunol Immunother VL - 64 UR - https://doi.org/10.1007/s00262-014-1613-0 DO - 10.1007/s00262-014-1613-0 ID - Kimura2015 ER - TY - JOUR AU - Yang, L. AU - Ren, B. AU - Li, H. AU - Yu, J. AU - Cao, S. AU - Hao, X. AU - Ren, X. PY - 2013 DA - 2013// TI - Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small cell lung cancer patients JO - Cancer Immunol Immunother VL - 62 UR - https://doi.org/10.1007/s00262-012-1311-8 DO - 10.1007/s00262-012-1311-8 ID - Yang2013 ER - TY - JOUR AU - Pan, Q. AU - Li, Q. AU - Liu, S. AU - Ning, N. AU - Zhang, X. AU - Xu, Y. AU - Chang, A. E. AU - Wicha, M. S. PY - 2015 DA - 2015// TI - Concise review: targeting cancer stem cells using immunologic approaches JO - Stem Cells VL - 33 UR - https://doi.org/10.1002/stem.2039 DO - 10.1002/stem.2039 ID - Pan2015 ER - TY - JOUR AU - Curiel, T. J. PY - 2012 DA - 2012// TI - Immunotherapy: a useful strategy to help combat multidrug resistance JO - Drug Resistance Updates VL - 15 UR - https://doi.org/10.1016/j.drup.2012.03.003 DO - 10.1016/j.drup.2012.03.003 ID - Curiel2012 ER - TY - JOUR AU - Nagase, H. AU - Takeoka, T. AU - Urakawa, S. AU - Morimoto-Okazawa, A. AU - Kawashima, A. AU - Iwahori, K. PY - 2017 DA - 2017// TI - ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori JO - Int J Cancer VL - 140 UR - https://doi.org/10.1002/ijc.30475 DO - 10.1002/ijc.30475 ID - Nagase2017 ER - TY - JOUR AU - Morisaki, T. AU - Onishi, H. AU - Koya, N. AU - Kiyota, A. AU - Tanaka, H. AU - Umebayashi, M. PY - 2011 DA - 2011// TI - Combinatorial cytotoxicity of gemcitabine and cytokine-activated killer cells in hepatocellular carcinoma via the NKG2D-MICA/B system JO - Anticancer Res VL - 31 ID - Morisaki2011 ER - TY - JOUR AU - Disis, M. L. AU - Bernhard, H. AU - Jaffee, E. M. PY - 2009 DA - 2009// TI - Use of tumour-responsive T cells as cancer treatment JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60404-9 DO - 10.1016/S0140-6736(09)60404-9 ID - Disis2009 ER - TY - JOUR AU - Nausch, N. AU - Cerwenka, A. PY - 2008 DA - 2008// TI - NKG2D ligands in tumor immunity JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.272 DO - 10.1038/onc.2008.272 ID - Nausch2008 ER - TY - JOUR AU - Onishi, H. AU - Morisaki, T. AU - Baba, E. AU - Nakamura, M. AU - Inaba, S. AU - Kuroki, H. PY - 2011 DA - 2011// TI - Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma JO - Anticancer Res VL - 31 ID - Onishi2011 ER - TY - JOUR AU - Nakagawa, S. AU - Nashimoto, A. AU - Yabusaki, H. PY - 2007 DA - 2007// TI - Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer JO - Gastric Cancer VL - 10 UR - https://doi.org/10.1007/s10120-006-0406-3 DO - 10.1007/s10120-006-0406-3 ID - Nakagawa2007 ER -